1The new prostacyclin analog treprostinilGU Zhi-chun, LIU Xiao-yan, SHEN Jie-yan, CAI Zong-ye2585-2588,25922Comparison of drug post-marketing studies among the different agenciesZHAO Jian-zhong, XIE Song-mei, YANG Jin-bo, WANG Tao2589-25923Appropriateness analysis for the regulation of drug post-marketing safety between the government and pharmaceutical companiesZHANG Hao, WU Zhi-ang2593-2596,26234Rules and regulations for off-label use of drug in US from the perspective of risk regulationXU Rong, SUN Xin-xin, SHAO Ming-li2597-2601,26505Research and development of the pediatric drugs in China:status and problem analysisGUO Zhi-gang, WU Bin, GUAN Xiao-dong, CONG Luo-luo, SHI Lu-wen2602-26066Establishment and advance of guidance system of nonclinical evaluation for pharmaceuticals in ChinaWANG Qing-li2607-2610,26587Effect of compound reserpine on intestinal flora in miceLI Hui-fen, CAO Yun-fei, CUI Wei-liang, ZHANG Xue-lan, TIAN Jing-zhen2611-2613,26638Simultaneous determination of fifteen components in Shuanghuanglian powder for injection by HPLCLI Wen-chun, SUN Yong-hui, XIE Li-wen, FU Rao, LI Chang-xin, SU De-long, WANG Ying-xin2614-2618,26309Isolation of endophytic bacteria from Acanthopanax senticosus and their antimicrobial activitiesGUO Xiao-lu, LU Bin-yu, ZHENG Chun-ying2619-262310Advance in research of anti-HCV drugs and therapiesYANG Xiao-yu, WANG Ju-xian2624-263011Application of polymeric micelles as new nanocarriers in cancer diagnosis and therapyXIAO Ya-nan, ZHANG Na2631-2636,267012Progress in synthesis research of the new proton pump inhibitor tenatoprazoleYAN Feng, MIN Jie, GUAN Jin, LIU Zhi-han2637-264213Quality control of clinical trial institution and the analysis of influence factors2643-264614A new electronic administration system of clinical trials in our hospitalWANG Ju-yong, XIAO Zhen, NI Shuang, LIU Tao, CHEN Chao, WANG Fang-yuan2647-265015Effect of low dose ketamine on visceral pain following laparoscopic cholecystectomyWU Chang-yi, YUE Feng, ZHANG Li-ping2651-265416A randomized controlled clinical trials for the treatment of type 2 diabetes by vildagliptin and alpha-glucosidase inhibitorSU Yong, L(U) Li-fang, LI Quan-zhong, ZHAO Zhi-gang2655-265817Pharmacokinetics of deoxypodophyllotoxin polymeric micelles in ratsZHAO Jin, SHI Ji-feng, XIONG Ye-rong, TU Jia-sheng2659-266318Optimization of smoked processing technology of Angelicae Sinensis Radix based on an AHP combined with BPNN modelGU Zhi-rong, PAN Xin-bo, WANG Ya-li, SUN Yu-jing2664-267019Preparation of controlled osmotic pump tablets of losartan potassium and hydrochlorothiazide and the optimization of formulation by central composite designLUO Dan-chao, WEIYANG Yi-fang, JIANG Jie, LI Ning, GAO Chong-kai2671-2677,268620TLC identification and content determination of Lignum caraganaeZHANG Xing-fu, LUO Gui-fa, WANG Yan2678-2680,2693 